Dextromethorphan/Bupropion: First Approval-Reference-Cited by-同舟云学术

Dextromethorphan/Bupropion: First Approval

Published:2022-10-27 Issue:11 Volume:36 Page:1229-1238
ISSN:1172-7047
Container-title:CNS Drugs
language:en
Short-container-title:CNS Drugs

Author:

Keam Susan J.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical)

Link

https://link.springer.com/content/pdf/10.1007/s40263-022-00968-4.pdf

Reference32 articles.

1. World Health Organisation. Depression fact sheet. 2021. https://www.who.int/news-room/fact-sheets/detail/depression. Accessed 13 Sep 2022.

2. Davoudian PA, Wilkinson ST. Clinical overview of NMDA-R antagonists and clinical practice. Adv Pharmacol. 2020;89:103–29.

3. Henter ID, Park LT, Zarate CA Jr. Novel glutamatergic modulators for the treatment of mood disorders: current status. CNS Drugs. 2021;35(5):527–43.

4. O'Gorman C, Jones A, Kennon K, et al. AXS-05 for neuropsychiatric disorders: scientific rationale and clinical development [abstract no. T16 plus poster]. In: ASCP 2018 Annual Meeting: Treatment of Psychiatric Illness Across the Lifespan. 2018.

5. Fenton C, Lee A. Glutamatergic modulators are poorly understood, but promising therapies in depressive disorders. Drugs Therapy Perspect. 2022;38(1):7–12.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bitter tastants relax the mouse gallbladder smooth muscle independent of signaling through tuft cells and bitter taste receptors;Scientific Reports;2024-08-08

2. Update on the assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form-2 (ATHF-SF2);Journal of Psychiatric Research;2024-08

3. Profiling the combination of bupropion and dextromethorphan as a treatment option for major depressive disorder;Expert Review of Neurotherapeutics;2024-07-22

4. Engineered Imine Reductase for Asymmetric Synthesis of Dextromethorphan Key Intermediate;Organic Letters;2024-05-15

5. Potential therapeutic strategies to halt viral neuroinvasion;Reviews in Medical Virology;2024-05